https://www.selleckchem.com/pr....oducts/gsk-j4-hcl.ht
Communicated by Ramaswamy H. Sarma.Coronavirus disease (COVID-19), a life-threatening disease, is caused by SARS-CoV-2. The targeted therapeutics of small molecules helps the scientific community to fight against SARS-CoV-2. In this article, some oxazine substituted 9-anilinoacridines (A1-A48) was designed by docking, MM-GBSA and molecular dynamics (MD) simulation studies for their COVID-19 inhibitory activity. The docking of ligands A1-A48 against SARS-CoV-2 (PDB ID 5R82) are performed by using Glide module, in silico ADMET screenin
Like
Comment
Share
